Breakthrough in pancreatic cancer treatment: Inhibiting specific enzymes slows tumor progression

Study demonstrates that inhibiting stromal class I histone deacetylases (HDACs) can effectively slow down pancreatic cancer progression, shedding light on a new therapeutic approach targeting the tumor microenvironment.

She once advised the president on aging issues. Now, she’s battling serious disability and depression.

The GoFundMe request jumped out at me as I was scrolling through posts on LinkedIn.

November 28, 2023

FDA proposes tightening restrictions on compounding three categories of drugs

The FDA is proposing to tighten its regulations on compounding three categories of drugs that the agency determined are too difficult to compound, according to

March 20, 2024

First Person in the U.S. May Be Executed Over Shaken Baby Syndrome

A Texas man this week could become the first person executed in the U.S. from a murder conviction tied to the diagnosis of shaken baby

October 15, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.